相关实验视频
Updated: Jun 19, 2026

09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.1K
诱导的mtDNA释放通过cGAS-STING信号在肝细胞中促进炎症反应
Hang Pan1, Qian Su1, Panjing Hong1
1College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Pesticide biochemistry and physiology
|October 30, 2024
概括
三氧化物 (ATO) 暴露会触发肝细胞中的线粒体DNA (mtDNA) 释放,激活cGAS-STING通路并引起炎症. 抑制这种途径可以减少ATO诱导的肝损伤.
科学领域:
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 化合物,特别是三氧化物 (ATO),是已知的肝毒素.
- 在ATO诱导的肝损伤中,循环GMP-AMP合成酶 (cGAS) 刺激干扰素基因 (STING) 途径的作用仍然未被探索.
研究的目的:
- 为了研究炎症反应与三氧化物诱导的肝毒性在的参与.
- 阐明通过cGAS-STING信号通路调解的ATO诱导肝损伤的机制.
主要方法:
- 肝细胞暴露于三氧化 (ATO).
- 评估线粒体DNA (mtDNA) 泄漏和cGAS-STING通路的激活 (测量cGAS,STING,TBK1,IRF7mRNA和蛋白质).
- 对I型干扰素和NF-κB信号通路的评估,包括促炎性细胞因子 (TNF-α,IL-6,IL-1β).
- 用乙基化物 (EtBr) 干预mtDNA清除和H-151抑制cGAS-STING通路.
主要成果:
- 暴露于ATO导致mtDNA泄漏到肝细胞的细胞质中.
- 这种泄漏激活了cGAS-STING通路,提高了关键信号分子的调节,并启动了I型干扰素反应.
- 激活STING导致NF-κB通路的激活,并增加了促炎性细胞因子的表达.
- mtDNA清除和cGAS-STING通路的抑制都逆转了ATO诱导的炎症反应.
结论:
- 肝细胞在ATO暴露后通过mtDNA-cGAS-STING通路激活先天免疫和炎症反应.
- 这种途径在ATO诱导的肝毒性机制中起着重要作用.
- 调查结果为了解ATO毒性和开发潜在干预措施提供了关键的见解.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

